CORDOVACANN CORP. Cost Of Sales
CORDOVACANN CORP. (LVRLF) reported Cost Of Sales of CAD 10.08 million for the 12-month period ending 2025-06-30, per its 20-F filed 2026-02-02.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-02-02
| Period end | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|
| 2025-06-30 | 10.08M CAD 20-F · filed 2026-02-02 | |
| 2024-06-30 | 9.72M CAD 20-F · filed 2026-02-02 | |
| 2023-06-30 | 9.73M CAD 20-F · filed 2026-02-02 | |
| 2022-06-30 | 9.80M CAD 20-F · filed 2025-04-28 | |
| 2021-06-30 | 6.83M CAD 20-F · filed 2023-12-28 | -6.83M CAD 20-F · filed 2021-12-15 |
| 2020-06-30 | 106.74K CAD 20-F · filed 2022-12-15 | -106.74K CAD 20-F · filed 2020-12-14 |
| 2019-06-30 | -30.53K CAD 20-F · filed 2021-12-15 | 30.53K CAD 20-F · filed 2019-12-12 |
| 2018-06-30 | 12.77K CAD 20-F · filed 2020-12-14 | |
| 2017-06-30 | 0.00 CAD 20-F · filed 2019-12-12 | |
| 2016-06-30 | 0.00 CAD 20-F · filed 2018-12-13 |